Starling Oncology, Inc. Long-Term Debt, Maturity, Remainder of Fiscal Year
Starling Oncology, Inc. (DFPH) had Long-Term Debt, Maturity, Remainder of Fiscal Year of $0 as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear · last filed 2026-08-06
- 2026-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $0.00.
- 2026-03-31: Long-Term Debt, Maturity, Remainder of Fiscal Year $0.00.
- 2025-09-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $0.00.
- 2025-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $0.00.
| Period end | Long-Term Debt, Maturity, Remainder of Fiscal Year |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-13 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-13 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-13 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-14 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-08 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-09 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-10 |